Prostate News Archive
11-Feb-2007
Iris Files for FDA Prostate Test OK (AP via Yahoo! Finance)
Medical test company Iris International Inc. said Wednesday that its Iris Molecular Diagnostics unit filed for Food and Drug Administration clearance for a more sensitive prostate cancer test. Gene Elevating Breast Cancer Risk Also Causes Prostate Cancer (Science Daily)
An international multicenter research effort has identified a new genetic defect as a potential heritable breast cancer susceptibility candidate. The same PALB2 mutation also seems to in some measure cause prostate cancer. Seven-Year Survival Data Demonstrate Use of Cytogen's PROSTASCINT(R) Independently Predicts Recurrence of Prostate ... (RedNova)
Cytogen Corporation (NASDAQ: CYTO) today reported the publication of a seven-year survival study that suggests PROSTASCINT® may help predict which patients are less likely to benefit from brachytherapy for prostate cancer.
Back to Prostate News Archive
